JENBURKT PHARMACEUTICALS
Back to Cashflow Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-8.86 Cr | ₹-7.62 Cr | ₹-7.08 Cr | ₹-21 Cr | ₹-5.53 Cr |
What is the latest Cash Flow from Financing Activities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-8.86 Cr |
| Mar2025 | ₹-7.62 Cr |
| Mar2024 | ₹-7.08 Cr |
| Mar2023 | ₹-21 Cr |
| Mar2022 | ₹-5.53 Cr |
How is Cash Flow from Financing Activities of JENBURKT PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-8.86 Cr | Negative | |
| Mar2025 | ₹-7.62 Cr | Negative | |
| Mar2024 | ₹-7.08 Cr | Negative | |
| Mar2023 | ₹-21 Cr | Negative | |
| Mar2022 | ₹-5.53 Cr | - | |
Compare Cash Flow from Financing Activities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹392.9 Cr | -0.3% | -6.7% | -13.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | -0.3% |
-6.7% |
-13.3% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses